Novel alleles of the Plasmodium falciparum dhfr highly resistant to pyrimethamine and chlorcycloguanil, but not WR99210

Molecular and Biochemical Parasitology

Volumn 117, Issue 1, 2001, Pages 91-102

  Hankins, Eleanor G ^a   Warhurst, David C ^b   Sibley, Carol Hopkins ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Antifolate; Drug resistance; Mutagenesis

Indexed keywords

4,6 DIAMINO 1,2 DIHYDRO 2,2 DIMETHYL 1 [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] 1,3,5 TRIAZINE; CHLORCYCLOGUANIL; DIHYDROFOLATE REDUCTASE INHIBITOR; FANSIDAR; N [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] N' ISOPROPYLIMIDOCARBONIMIDIC DIAMIDE; PYRIMETHAMINE; SULFADOXINE;

ALLELE; ANIMAL MODEL; ARTICLE; CODON; CONTROLLED STUDY; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME INHIBITION; GENE MUTATION; GENETIC CODE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; MALARIA; MUTANT; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STRAIN DIFFERENCE; YEAST;

PLASMODIUM FALCIPARUM; SACCHAROMYCES CEREVISIAE; SACCHAROMYCETALES; STAPHYLOCOCCUS PHAGE 187;

EID: 0034844550     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(01)00335-8     Document Type: Article

References (60)

1. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria
2. Molecular epidemiology of malaria in Yaounde, Cameroon I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum
3. Mutant dihydrofolate reductase-thymidylate synthase genes in pyrimethamine-resistant Plasmodium falciparum with polymorphic chromosome duplications
4. Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone
5. Pyrimethamine resistant mutations in Plasmodium falciparum
6. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea
7. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins
8. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase
9. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance
10. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: Polymerase chain reaction methods for surveillance in Africa
11. Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand
12. Molecular assays for surveillance of antifolate-resistant malaria
13. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: Correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes
14. High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance
15. The dihydrofolate reductase-thymidylate synthase gene in the drug resistance of malaria parasites
16. Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates
17. Association between antifol resistance in vitro and DHFR gene point mutation in Plasmodium falciparum isolates
18. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum
19. The mechanisms of drug action and resistance in malaria
20. Antimalarial drug resistance: The pace quickens
21. Epidemiology of drug resistance in malaria
22. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: Genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites
23. The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya
24. Antimalarial drug discovery: Development of inhibitors of dihydrofolate reductase active in drug resistance
25. Towards an understanding of drug resistance in malaria: Three-dimensional structure of Plasmodium falciparum dihydrofolate reductase by homology building
26. Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: Structural basis of antifolate resistance
27. Chlorproguanil-dapsone: Effective treatment for uncomplicated falciparum malaria
28. Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum
29. Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: Pharmacokinetics and therapeutic range
30. The efficacy of antifolate antimalarial combinations in Africa: A predictive model based on pharmacodynamic and pharmacokinetic analyses
31. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated falciparum malaria in Thailand
32. In vitro activities of and mechanisms of resistance to antifol antimalarial drugs
33. Plasmodium falciparum: Direct cloning and expression of pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase domains
34. PS-15: A potent, orally active antimalarial from a new class of folic acid antagonists
35. Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model
36. The phenotype of a dihydrofolate reductase mutant in Saccharomyces cerevisiae
37. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum
38. Randomization of genes by PCR mutagenesis
39. Hypermutagenic PCR involving all four transitions and a sizeable proportion of transversions
40. Random mutagenesis of gene-sized DNA molecules by use of PCR with Taq DNA polymerase
41. Yeast as a model system to study drugs effective against apicomplexan proteins
42. A system or shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae
43. Nucleotide sequence of the dihydrofolate reductase gene of Saccharomyces cerevisiae
44. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene
45. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast
46. Transformation of intact yeast cells treated with alkali cations
47. Identification and analysis of dihydrofolate reductase alleles from Plasmodium falciparum present at low frequency in polyclonal patient samples
48. Efficacies of lipophilic inhibitors of dihydrofolate reductase against parasitic protozoa
49. Mutagenesis of dihydrofolate reductase from Plasmodium falciparum: Analysis in Saccharomyces cerevisiae of triple mutant alleles resistant to pyrimethamine or WR99210
50. Correlation of mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase with patterns of in vivo resistance to pyrimethamine-sulfadoxine
51. In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment
52. In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine
53. Population genetics and dynamics of Plasmodium falciparum: An ecological view
54. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance
55. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria
56. Analogues of N-benzyloxydihydrotriazines: In vitro antimalarial activity against Plasmodium falciparum
57. Molscript: A program to produce both detailed and chematic plots of protein structure
58. Raster3D version 2.0, A Program for Photorealistic Molecular Graphics